EPM speaks to Rami Cassis, executive chairman of pharmaceutical serialisation company Advanco and CEO of Parabellum Investments about the rise in counterfeit medicines during the Covid-19 pandemic.
Counterfeit
EPM: Has there been a rise in counterfeit medicines during the Covid-19 pandemic?
Cassis: It certainly seems so. The World Health Organisation has recently warned against a surge in fake medicines, notably in the developing world, and Interpol’s global pharmaceutical crime fighting unit has reportedly made 121 arrests across 90 countries in just seven days, resulting in the seizure of dangerous pharmaceuticals worth over $14m (£11m).